Results 51 to 60 of about 4,782 (272)

Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids : A Historical Cohort Study [PDF]

, 2017
This work was supported by the Respiratory Effectiveness Group. Acknowledgments We thank the Respiratory Effectiveness Group for funding this work, Annie Burden for assistance with statistics, and Simon Van Rysewyk and Lisa Law for assistance with ...
Murray, Claire S., Price, David B., Richardson, Kathryn, Thomas, Mike, Turner, Steve W.   +4 more
core   +2 more sources

Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: A Spanish National Healthcare System perspective [PDF]

, 2018
Background: A head-to-head study demonstrated the superiority of once-daily umeclidinium bromide/vilanterol (UMEC/VI) 62.5/25 mcg on trough forced expiratory volume in 1 s (FEV1) versus once-daily tiotropium/olodaterol (TIO/OLO) 5/5 mcg in symptomatic ...
Alcázar-Navarrete, B., Asukai, Y., Driessen, M. T., García-Río, F., Miravitlles, Marc, Naya, I. P., Risebrough, N. A., Seewoodharry Buguth, B., Vallejo-Aparicio, L. A., Whalen, J.   +9 more
core   +4 more sources

Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease : The Finnish Guidelines [PDF]

, 2015
Peer ...
Anthonisen NR, Appleton S, Appleton S, Appleton S, Barr RG, Cates CJ, Chong J, Chronic Obstructive Pulmonary Disease (online), Donohue JF, Haahtela T, Harju T, Harju T, Hay JG, Higgings BG, Kankaanranta H, Kankaanranta H, Kankaanranta H, Karner C, Karner C, Karner C, Kew KM, Kew KM, Lehtimäki L, Mohamed Hoesein FA, Nannini LJ, Nannini LJ, Nannini LJ, Nannini LJ, Poole P, Poole PJ, Ram FS, Sestini P, Tobacco Dependence and Cessation (online), Walters JA, Yang IA   +34 more
core   +2 more sources

The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum]

International Journal of COPD, 2019
Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH. Int J Chron Obstruct Pulmon Dis. 2019;14:1539–1548. The authors advised that they have introduced errors while preparing this article which were oversighted by all authors.On page 1541, in Results section, Risk of moderate or severe COPD exacerbation; (rate ratio, 0.81; 95% CI, 0.73 to 0.89, I2=29 ...
Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH   +4 more
openaire   +9 more sources

Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England

International Journal of COPD, 2023
Gema Requena,1 Victoria Banks,2,* Alexandrosz Czira,1 Robert Wood,2 Theo Tritton,2 Rosie Wild,2 Chris Compton,1 Afisi S Ismaila3,4 1Value Evidence and Outcomes, GSK, R&D Global Medical, Brentford, Middlesex, UK; 2Real-World Evidence, Adelphi Real ...
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Ismaila AS   +7 more
doaj  

Association between blood procollagen III N-terminal propeptide, granulocyte-macrophage colony-stimulating factor and triple therapy in single inhaler efficacy for chronic obstructive pulmonary disease re-exacerbation prevention

Сибирский научный медицинский журнал
Triple therapy with inhaled corticosteroid (ISC) / long-acting β2 agonist (LABA) / long-acting muscarinic antagonist (LAMA) in single inhaler expanded the possibilities for prevention of chronic obstructive pulmonary disease (COPD) exacerbations ...
L. A. Shpagina, О. S. Kotova, I. S. Shpagin, Е. М. Loktin, G. V. Kuznetsova, S. A. Karmanovskaya, L. A. Panacheva, E. V. Anikina   +7 more
doaj   +1 more source

Effects of adding Tiotropium or Aclidinium as triple therapy using impulse oscillometry in COPD [PDF]

, 2016
INTRODUCTION: Long-acting muscarinic antagonists confer improvements in spirometry when used in addition to inhaled corticosteroids and long-acting beta-agonists (ICS/LABA) in COPD.
A Gavalda, AE Holland, Arvind Manoharan, Ashley E. Morrison, Brian J. Lipworth, C Crim, D Singh, J Beier, J Vestbo, KS Jung, M Cazzola, M Cazzola, MA Puhan, NA Hanania, PA Frith, PA Williamson, PA Williamson, PM Short, R Fuhr, SD Aaron, T Welte, TJ Witek Jr, WJ Anderson   +22 more
core   +3 more sources

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

Inhaled corticosteroids for chronic obstructive pulmonary disease-the shifting treatment paradigm [PDF]

, 2015
Chronic obstructive pulmonary disease (COPD) guidelines suggest using inhaled corticosteroids (ICS) in patients with severe airflow limitation or those at high risk of exacerbations.
Duerden M, Miller DP, Morven Wilkie, Nannini LJ, Senderovitz T, Simon Finch, Stuart Schembri, Vestbo J, Yang IA   +8 more
core   +2 more sources

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial

International Journal of Chronic Obstructive Pulmonary Disease, 2022
Given between-country differences in healthcare systems, treatment costs, and disease management guidelines, country-specific cost-effectiveness analyses are important. This study evaluated the cost-effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI and UMEC/VI among patients with symptomatic chronic ...
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan Martin, José Luis Izquierdo, Juan Antonio Riesco, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila   +8 more
openaire   +5 more sources